First, let's get it straight, this page reveals research showing that ingestion of concentrated cannabis bud oil has extreme medicinal benefits. This article is not about 'smoking' marijuana for recreational purposes. The two topics are completely different.
Here is just one study which shows the results: "Cannabinoids including THC, induce apoptosis in leukemic cells"
http://www.ncbi.nlm.nih.gov/pubmed/16908594
The government study was done by Jia W, Hegde VL, Singh NP, Sisco D, Grant S, Nagarkatti M, Nagarkatti PS at the Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, USA.
To quote: "Cannabinoids including THC, induce apoptosis in leukemic cells" PMID: 16908594
A professional's look into recent research of medical marijuana:
Cannabis & Cannabinoids, by Robert Melamede PhD and of late, but the bulk of the following information comes from:
http://norml.org/index.cfm?Group_ID=7002
"Despite the ongoing political debate regarding the legality of medical marijuana, clinical investigations of the therapeutic use of cannabinoids are now more prevalent than at any time in history.
Around the globe, similarly controlled trials are also taking place. A 2010 review by researchers in Germany reports that since 2005 there have been 37 controlled studies assessing the safety and efficacy of marijuana and its naturally occurring compounds in a total of 2,563 subjects. By contrast, most FDA-approved drugs go through far fewer trials involving far fewer subjects.
While much of the renewed interest in cannabinoid therapeutics is a result of the discovery of the endocannabinoid regulatory system (which we describe in detail later in this booklet), some of this increased attention is also due to the growing body of testimonials from medical cannabis patients and their physicians. Nevertheless, despite this influx of anecdotal reports, much of the modern investigation of medical cannabis remains limited to preclinical (animal) studies of individual cannabinoids (e.g. THC or cannabidiol) and/or synthetic cannabinoid agonists (e.g., dronabinol or WIN 55,212-2) rather than clinical trial investigations involving whole plant material. Because of the US government's strong public policy stance against any use of cannabis, the bulk of this modern cannabinoid research is predictably taking place outside the United States.
As clinical research into the therapeutic value of cannabinoids has proliferated – there are now an estimated 20,000 published papers in the scientific literature analyzing marijuana and its constituents — so too has investigators' understanding of cannabis' remarkable capability to combat disease. Whereas researchers in the 1970s, 80s, and 90s primarily assessed cannabis' ability to temporarily alleviate various disease symptoms — such as the nausea associated with cancer chemotherapy — scientists today are exploring the potential role of cannabinoids to modify disease.
Of particular interest, scientists are investigating cannabinoids' capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig's disease.) In fact, in 2009, the American Medical Association (AMA) resolved for the first time in the organization's history "that marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines."
Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels). Arguably, these latter findings represent far broader and more significant applications for cannabinoid therapeutics than researchers could have imagined some thirty or even twenty years ago."
Former CBC television announcer, Lloyd Robertson, spoke of this on one of his evening news broadcasts a few years ago - and the lady he was interviewing was very honest by saying - "If there is no profit to be made, no company will want to sell something that will not make them $$$$".
I don't condone smoking marijuana, but the oil is what is needed by so many people.
Please take five minutes to watch this, it could help you or someone you love one day.
http://dotsub.com/media/fc4e051a-1709-4e63-8a2c-912b09486c9f/e/m
Medicinal oil made from cannabis buds, when ingested (see dosage instructions below) three to four times daily, for three months, will destroy leukemia and cancer cells. This means ingesting about 1/5 teaspoon, or one ml, or one gram per day....So that over two months one has ingested 60 grams or 60 ml in total. One must start with one half a rice-grain size portion of cannabis oil, thrice daily....and, over the next four weeks, work up to the amount of about four rice-grains of cannabis oil, four times per day, for two months. One must take one gram or one ml. per day for 60 days.
Here is the link to the proper dosage instructions:
http://phoenixtears.ca/dosage-information/
Below is the full length documentary titled: "Run From The Cure - The Rick Simpson Story"
http://www.youtube.com/watch?v=0psJhQHk_GI
Any questions you have will be answered by watching this video presentation. Of course there will be those who doubt the studies, research and testimonials....However, this research is for those with confidence that cancer can be beaten.
The URL link to the above video interview titled: "Prostrate Cancer Cured with Cannabis Oil"
http://www.youtube.com/watch?v=ym0BSdEIjJA
URL for this web page is: http://www.blissful-wisdom.com/thc-from-cannabis-marijuana-bud-oil-destroys-luekemia-and-cancer-cells.html
